JPH0344331A - Collagenase inhibitor - Google Patents
Collagenase inhibitorInfo
- Publication number
- JPH0344331A JPH0344331A JP1177186A JP17718689A JPH0344331A JP H0344331 A JPH0344331 A JP H0344331A JP 1177186 A JP1177186 A JP 1177186A JP 17718689 A JP17718689 A JP 17718689A JP H0344331 A JPH0344331 A JP H0344331A
- Authority
- JP
- Japan
- Prior art keywords
- collagenase
- cacao
- collagenase inhibitor
- extracted
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002442 collagenase inhibitor Substances 0.000 title claims abstract description 32
- 101000645291 Bos taurus Metalloproteinase inhibitor 2 Proteins 0.000 title claims abstract description 28
- 229940122097 Collagenase inhibitor Drugs 0.000 title claims abstract description 28
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 title claims abstract description 28
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 title claims abstract description 28
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 42
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims abstract description 33
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims abstract description 33
- 235000001046 cacaotero Nutrition 0.000 claims abstract description 33
- 239000010903 husk Substances 0.000 claims abstract description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 18
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 7
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 6
- 239000003960 organic solvent Substances 0.000 claims abstract description 6
- 238000000605 extraction Methods 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- 230000009965 odorless effect Effects 0.000 abstract description 6
- 230000009967 tasteless effect Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 235000015218 chewing gum Nutrition 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 210000000214 mouth Anatomy 0.000 abstract description 3
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000029816 Collagenase Human genes 0.000 description 19
- 108060005980 Collagenase Proteins 0.000 description 19
- 229960002424 collagenase Drugs 0.000 description 19
- 230000000694 effects Effects 0.000 description 17
- 241000605862 Porphyromonas gingivalis Species 0.000 description 9
- 208000028169 periodontal disease Diseases 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 235000009470 Theobroma cacao Nutrition 0.000 description 4
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229930014626 natural product Natural products 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000034391 chronic adult periodontitis Diseases 0.000 description 1
- 208000001277 chronic periodontitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Confectionery (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、カカオ植物の所定の部分から抽出して得られ
るコラゲナーゼ阻害剤に関し、更に詳しくは、これを用
いて歯周病の病原菌として知られているBactero
ides gingivalis(バクテロイデス・ジ
ンジバリス)の産生ずるコラゲナーゼを阻害することに
より歯周病の予防および治療を図るコラゲナーゼ阻害剤
に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a collagenase inhibitor obtained by extraction from a predetermined part of a cacao plant, and more specifically, the present invention relates to a collagenase inhibitor obtained by extracting from a predetermined part of a cacao plant. Bactero
The present invention relates to a collagenase inhibitor for preventing and treating periodontal disease by inhibiting collagenase produced by Bacteroides gingivalis.
[従来の技術] 歯周病は細菌性由来の炎症性疾患である。[Conventional technology] Periodontal disease is an inflammatory disease of bacterial origin.
歯周病の中では成人性歯周炎が最も多いが、この病因と
して、歯周組織のコラーゲン線維がコラゲナーゼによっ
て破壊されるとする説が有力であり、このコラゲナーゼ
は、患者の歯周ポケットから多数分離されるバクテロイ
デス・ジンジバリスが生産するものと考えられている。Adult periodontitis is the most common type of periodontal disease, and the leading theory is that collagen fibers in the periodontal tissue are destroyed by collagenase, which is released from the patient's periodontal pocket. It is thought to be produced by Bacteroides gingivalis, which has been isolated in large numbers.
バクテロイデス・ジンジバリスは、血液平板上で黒色の
コロニーを形成する非運動性のダラム陰性個性嫌気性桿
菌であり、その病原性因子についての解明が進展しつつ
ある。Bacteroides gingivalis is a non-motile Durham-negative individual anaerobic bacillus that forms black colonies on blood plates, and progress is being made in elucidating its virulence factors.
歯周病の病原菌として最も有力視されているバクテロイ
デス・ジンジバリスは様々な蛋白質分解酵素を産生ずる
が、その中でも歯周組織の破壊を導く直接的な因子とさ
れるコラゲナーゼを特異的に阻害することができれば、
歯周病の予防および治療を有効に達成し得ると考えられ
る。Bacteroides gingivalis, which is considered to be the most likely causative agent of periodontal disease, produces various proteolytic enzymes, but among these, we can specifically inhibit collagenase, which is a direct factor that leads to the destruction of periodontal tissues. If possible,
It is believed that prevention and treatment of periodontal disease can be effectively achieved.
歯周病の予防および治療に用いることを意図するコラゲ
ナーゼ阻害剤は、口腔内で使用するものであるため、安
全性の観点から合成物よりも天然抽出物、理想的には、
古くから人類が食用とし人体に無害であると認められて
いる食用素材から抽出されたものであることが望ましい
、更に、口腔用として使用するためには、呈味性良好で
あるか、またはそれ自体無味無臭であることも必要であ
る。また、天然物から抽出したものであっても、原料と
する天然物が希少で入手困難なものや、複雑な抽出vi
製工程を要するものはコスト的に問題があり、工業的に
利用するには不適切である。Collagenase inhibitors intended for use in the prevention and treatment of periodontal disease are intended for use in the oral cavity, so from a safety point of view natural extracts are preferred over synthetic ones, ideally.
It is desirable that the material is extracted from an edible material that has been used by humans since ancient times and is recognized as being harmless to the human body.Furthermore, in order to be used for the oral cavity, it must have a good taste or taste. It is also necessary that it itself be tasteless and odorless. In addition, even if the product is extracted from a natural product, the natural product used as the raw material may be rare and difficult to obtain, or the extraction process may be complicated.
Those that require a manufacturing process are problematic in terms of cost and are inappropriate for industrial use.
コラゲナーゼに対する阻害剤として、例えばテトラサイ
クリンのような合成薬剤が幾つか報告されているが、天
然物に関する報告は殆どなく、僅かに大豆抽出物(特開
昭61−275224号および特開昭62−28692
6号)があるのみである。Several synthetic drugs such as tetracycline have been reported as collagenase inhibitors, but there are almost no reports on natural products, and only soybean extracts (Japanese Patent Application Laid-Open Nos. 61-275224 and 62-28692) have been reported.
No. 6).
[発明が解決しようとする課題]
本発明は、安全性、良好な呈味性または無味無臭性、入
手容易性並びに抽出容易性を備え、かつ安価な原料から
抽出した抽出物からなる有効なコラゲナーゼ阻害剤を提
供することを目的とする。[Problems to be Solved by the Invention] The present invention provides an effective collagenase that is safe, has good taste, is tasteless and odorless, is easily available, and is easy to extract, and is made from an extract extracted from inexpensive raw materials. The purpose is to provide inhibitors.
[課題を解決するための手段]
本発明によれば、カカオ豆の豆皮であるカカオハスクよ
り抽出した抽出物からなることを特徴とするコラゲナー
ゼ阻害剤が提供される。[Means for Solving the Problems] According to the present invention, there is provided a collagenase inhibitor characterized by comprising an extract extracted from cacao husk, which is the hull of cacao beans.
このコラゲナーゼ阻害剤は、カカオ豆の豆皮であるカカ
オハスクより抽出して製造するが、好ましくはカカオハ
スクの疎水性物質を有機溶媒で除去後、水で抽出するこ
とにより製造することができ、これにより抽出効率を上
げることができる。This collagenase inhibitor is produced by extracting from cacao husk, which is the hull of cacao beans, and preferably by removing hydrophobic substances from cacao husk with an organic solvent and then extracting with water. Extraction efficiency can be increased.
コラゲナーゼ阻害剤が、カカオ豆の豆皮であるカカオハ
スクより有機溶媒で抽出される疎水性物質を含有せず、
水で抽出されない抽出残渣を含有しないものであれば好
適である。The collagenase inhibitor does not contain hydrophobic substances that are extracted with organic solvents from cacao husk, which is the skin of cacao beans.
It is suitable if it does not contain extraction residues that cannot be extracted with water.
有機溶媒が、ヘキサン、アセトン並びにアルコールより
なる群から選択されれば好適である。It is preferred if the organic solvent is selected from the group consisting of hexane, acetone and alcohol.
カカオ豆の豆皮であるカカオハスクが、カカオ豆焙煎後
に分離される豆皮であれば好適である。It is preferable that the cacao husk, which is the bean skin of cacao beans, is a bean skin that is separated after roasting the cacao beans.
本発明によるコラゲナーゼ阻害剤は、例えば、カカオハ
スク100gを粉砕した後、1000〜5000旧のヘ
キサンを加え、室温で10〜30時間抽出してカカオハ
スクの脱脂を行い、必要に応じて抽出残渣に更に100
0〜5000IIIのエタノールを加え、室温で10〜
30時間抽出してヘキサンによっては除去しきれない疎
水性物質を抽出除去し、その後抽出残渣に1000〜5
00011の水を加え、室温で10〜30時間抽出して
抽出液を得、この水抽出液を乾固または凍結乾燥するこ
とにより製造することができ、これにより10〜15g
の本発明によるコラゲナーゼ阻害剤を得ることができる
。The collagenase inhibitor according to the present invention can be prepared, for example, by crushing 100 g of cacao husk, adding 1000 to 5000 g of hexane, and extracting at room temperature for 10 to 30 hours to defatte the cacao husk.
Add 0-5000III ethanol and heat at room temperature for 10-5000
Extract for 30 hours to remove hydrophobic substances that cannot be removed by hexane.
00011 and extracted at room temperature for 10 to 30 hours to obtain an extract, and drying or freeze-drying this aqueous extract, whereby 10 to 15 g
A collagenase inhibitor according to the present invention can be obtained.
カカオハスクは、カカオ(TheobroIlacac
ao、L、 )の種皮(豆殻)であり、ココアパウダー
やチョコレート製造過程で得られるものや、通常のカカ
オ豆から得られるものを使用することができる。カカオ
ハスクはMI維質であり、リグニン類、タンニン類、多
糖類等を成分とすると考えられるが、詳細は明らかでは
ない、しかしながら、本発明が開示した所定の方法によ
ってカカオハスクを水抽出することにより、コラゲナー
ゼ阻害剤を得ることができる。Cacao Husk
This is the seed coat (bean shell) of cacao, L, ), and can be obtained from cocoa powder or chocolate manufacturing process, or from ordinary cacao beans. Cocoa husk is MI fiber and is thought to contain lignins, tannins, polysaccharides, etc., but the details are not clear.However, by extracting cacao husk with water using the prescribed method disclosed in the present invention, Collagenase inhibitors can be obtained.
また、本発明によるコラゲナーゼ阻害剤は、呈味性が低
く実質的に無味無臭であり、食品中への添加に非常に適
した素材であるため、本発明によるコラゲナーゼ阻害剤
を、チューインガム、キャンデイ、飲料等に配合するこ
とによって、歯周病予防!l!能を有する口腔用組成物
を提供することができる。この場合、本発明によるコラ
ゲナーゼ阻害剤を、好ましくは、0.01〜1重量5!
≦程度添加する。In addition, the collagenase inhibitor according to the present invention has a low taste and is substantially tasteless and odorless, and is a material that is very suitable for addition to foods. Therefore, the collagenase inhibitor according to the present invention can be used in chewing gum, candy, Prevent periodontal disease by adding it to drinks, etc. l! It is possible to provide an oral composition having the following properties. In this case, the collagenase inhibitor according to the invention is preferably used from 0.01 to 1% by weight.
Add about ≦.
[作用]
バクテロイデス・ジンジバリスの産生するコラゲナーゼ
活性阻害物質を開発すべく研究を重ねた結果6.カカオ
ハスクの水抽出物に強いコラゲナーゼ活性阻害効果があ
ることを突き止めた0本発明は、この知見に基づいて完
成されたものである。[Action] As a result of repeated research to develop a substance that inhibits collagenase activity produced by Bacteroides gingivalis 6. The present invention was completed based on this finding, which revealed that a water extract of cacao husk has a strong inhibitory effect on collagenase activity.
カカオハスクは、チョコレート製造過程においてカカオ
豆から分離される豆皮であり、これを用いて従来テオブ
ロミンや色素等が抽出されていたが、現在では特に有用
な用途がなく、その殆どが廃棄処分されているのが実状
である。したがって、カカオハスクのコラゲナーゼ活性
阻害作用という新しい効果を突き止めたことは、廃棄物
の有効利用という観点からも極めて意義深く、歯周病予
防および治療用素材として、十分実用化し得るものと考
えられる。Cocoa husks are bean husks separated from cacao beans during the chocolate manufacturing process, and theobromine and pigments have been extracted from them in the past, but they currently have no particularly useful use and most of them are disposed of. The reality is that there are. Therefore, the discovery of the new effect of cacao husk in inhibiting collagenase activity is extremely significant from the perspective of effective utilization of waste, and it is thought that it can be fully put to practical use as a material for the prevention and treatment of periodontal disease.
[発明の効果]
本発明によれば、安全性、実質的な無味無臭性、入手容
易性並びに抽出容易性を備え、かつ安価な原料から抽出
した抽出物からなる有効なコラゲナーゼ阻害剤が提供さ
れる。[Effects of the Invention] According to the present invention, an effective collagenase inhibitor is provided that is safe, substantially tasteless and odorless, easily available, and easy to extract, and is made of an extract extracted from inexpensive raw materials. Ru.
本発明によるコラゲナーゼ阻害剤は、チョコレート製造
過程で廃棄処分されているカカオハスクを原料とするた
め非常に低コストであり、また、IQOgのカカオハス
クより10〜15g抽出されるため非常に抽出効率が良
く、更に、安全性の高い天然物であると共に呈味性が低
く実質的に無味無臭であるため食品中への添加に非常に
適した素材であり、歯周病予防および治療用素材として
十分実用化し得るものである。The collagenase inhibitor according to the present invention is very low cost because it is made from cacao husk, which is discarded during the chocolate manufacturing process, and has very high extraction efficiency because it is extracted from 10 to 15 g of IQOg cacao husk. Furthermore, it is a highly safe natural product and has a low taste and is virtually odorless, making it an extremely suitable material for addition to food, and has been put to practical use as a material for the prevention and treatment of periodontal disease. It's something you get.
[実施例]
以下に実施例により本発明を更に詳細に説明するが、本
発明は以下の実施例にのみ限定されるものではない。[Examples] The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited only to the following Examples.
去1u生上
次の工程によりカカオハスクからコラゲナーゼ阻害剤を
抽出した。Collagenase inhibitors were extracted from cocoa husk by the following steps.
カカオハスク100gを粉砕した後、10001′I1
1のヘキサンを加え、室温で24時間抽出してカカオハ
スクの脱脂を行い、抽出残渣に更に100Q+ulのエ
タノールを加え、室温で24時間抽出してヘキサンによ
っては除去しきれない疎水性物質を抽出除去し、その後
抽出残渣に1000m lの水を加え、室温で24時間
抽出して抽出液を得、この水抽出液を乾固または凍結乾
燥することにより、10〜15gの本発明によるコラゲ
ナーゼ阻害剤を得た。After crushing 100g of cacao husk, 10001'I1
Add hexane from step 1 and extract at room temperature for 24 hours to defatte the cacao husk. Add 100Q+ul of ethanol to the extraction residue and extract at room temperature for 24 hours to extract and remove hydrophobic substances that cannot be removed by hexane. Then, 1000 ml of water was added to the extraction residue and extracted for 24 hours at room temperature to obtain an extract, and this water extract was dried or freeze-dried to obtain 10 to 15 g of the collagenase inhibitor according to the present invention. Ta.
X生型ユ
前記したようにして調製した本発明によるコラゲナーゼ
阻害剤のコラゲナーゼ阻害活性を測定した。The collagenase inhibitory activity of the collagenase inhibitor of the present invention prepared as described above was measured.
コラゲナーゼ活性の測定は、コラゲナーゼ)CLN−1
00<登録商標、コスモバイオ株式会社)を用いて行っ
た6本キットは、螢光標識コラーゲンを基質とし、コラ
ゲナーゼ反応後に生じる分解物を抽出し、その螢光光度
を測定することにより、コラゲナー・セ活性を定量する
ものである。For measurement of collagenase activity, collagenase) CLN-1
00 (registered trademark, CosmoBio Co., Ltd.) uses fluorescently labeled collagen as a substrate, extracts the decomposed product produced after the collagenase reaction, and measures the fluorescence intensity. It is used to quantify cell activity.
コラゲナーゼ活性阻害試料として、本発明によるコラゲ
ナーゼ阻害剤およびコラゲナーゼ活性阻害効果が確認さ
れている塩酸テトラサイクリン(例えば、臼歯周誌第3
0巻1号、第182〜190頁を参照するとよい〉を用
いて、その効果の比較を行った。As a collagenase activity inhibition sample, the collagenase inhibitor according to the present invention and tetracycline hydrochloride, which has been confirmed to have a collagenase activity inhibition effect (for example,
Please refer to Vol. 0, No. 1, pp. 182-190) to compare their effects.
本実施例で用いたバクテロイデス・ジンジバリスのコラ
ゲナーゼ溶液は以下の方法により調製した。The Bacteroides gingivalis collagenase solution used in this example was prepared by the following method.
血液平板培地を用いて4日間嫌気的に培養を行ったバク
テロイデス・ジンジバリスFDC381株を、トリブチ
カーゼ・ソイ
(Trypt 1case SOV )液体培地150
0n+Iに接種し、3日間嫌気的に培養した。培養液を
遠心分離(12,0OOx G、20分間、4℃)し、
上澄を80%硫酸アンモニウム飽和とし、遠心分離(1
2,0OOx G、20分間、4°C)を行って80%
硫安画分を集めた。この画分を0.05M トリス−H
Cl綬8液(pH7,5) 300 nlに溶解し、0
622μmのフィルタでろ過し、これをバクテロイデス
・ジンジバリスのコラゲナーゼ溶液とした。Bacteroides gingivalis strain FDC381, which had been cultured anaerobically for 4 days using blood plate medium, was cultured in Tributicase soy (Trypt 1case SOV) liquid medium 150 g.
On+I was inoculated and cultured anaerobically for 3 days. The culture solution was centrifuged (12,000 x G, 20 minutes, 4°C),
The supernatant was brought to 80% ammonium sulfate saturation and centrifuged (1
2,0OOx G, 20 minutes, 4°C) to 80%
The ammonium sulfate fraction was collected. This fraction was mixed with 0.05M Tris-H
Dissolved in 300 nl of Cl 8 solution (pH 7.5), 0
It was filtered through a 622 μm filter and used as a Bacteroides gingivalis collagenase solution.
基質コラーゲン溶液は、0.05%螢光標識コラーゲン
を含有する0、05M トリス−HCl 455液(p
H7,5)とし、また、試料溶液は、本発明によるコラ
ゲナーゼ阻害剤および塩酸テトラサイクリンを0.05
M トリス−HCl 11街液(pH7,5)を用いて
所定の濃度に調整したものとした。The matrix collagen solution was 0.05M Tris-HCl 455 (p) containing 0.05% fluorescently labeled collagen.
H7,5), and the sample solution contained 0.05% of the collagenase inhibitor according to the present invention and tetracycline hydrochloride.
The concentration was adjusted to a predetermined concentration using M Tris-HCl 11 solution (pH 7.5).
実験系は、バクテロイデス・ジンジバリスのコラゲナー
ゼ溶液200μm、基質コラーゲン溶液200 pi並
びに試料溶液100 Elからなる計500μmとし、
35℃で2時間反応を行い、分解物の螢光強度によりコ
ラゲナーゼ活性の測定を行った。結果を以下に示す、な
お、活性の単位tUは、1分間に1μgのコラーゲンを
分解する酵素量とした。The experimental system was a total of 500 μm consisting of 200 μm of Bacteroides gingivalis collagenase solution, 200 pi of matrix collagen solution, and 100 El of sample solution.
The reaction was carried out at 35°C for 2 hours, and the collagenase activity was measured based on the fluorescence intensity of the decomposed product. The results are shown below; the unit of activity, tU, is the amount of enzyme that decomposes 1 μg of collagen per minute.
波目 lえ±X± 活性 止−a豆−〔2」−(n
u/n+I)
と全量
521
主五旦亙よ玉コラゲナーゼ匪豊田
0.1 324
0.05 503
0.01 706
0.005 1191
0.001 1492
髭艷立五二二エヱユ之
0.1 385
(1,05584
0,011088
00
5
8
2
0,005122380
0,001149298
これらの結果から、本発明によるコラゲナーゼ阻害剤の
阻害活性は、活性阻害物質として知られている塩酸テト
ラサイクリンより強く、その阻害の程度は添加濃度に依
存して増加し、0.01%の添加により50%以上の阻
害活性〈コラゲナーゼの比活性は46%〉を示すことが
分る。Wave pattern 1±X± Activity stop-a bean-[2''-(n
u/n+I) and total amount 521 Lord Godanko Yotama Collagenase Utoyoda 0.1 324 0.05 503 0.01 706 0.005 1191 0.001 1492 Bearded 522 Eyu no 0.1 385 (1 ,05584 0,011088 00 5 8 2 0,005122380 0,001149298 From these results, the inhibitory activity of the collagenase inhibitor according to the present invention is stronger than that of tetracycline hydrochloride, which is known as an activity inhibitor, and the degree of inhibition is greater than that of tetracycline hydrochloride, which is known as an activity inhibitor. It can be seen that the inhibitory activity increases depending on the concentration, and the addition of 0.01% shows an inhibitory activity of 50% or more (the specific activity of collagenase is 46%).
監旌旦ユ
本発明によるコラゲナーゼ阻害剤を使用して、次の処方
によりチューインガムを製造した。Chewing gum was manufactured using the collagenase inhibitor according to the present invention according to the following formulation.
直置 ガムベース 砂糖 グルコース 水飴 香料 本発明による 旦遮(1!!菫上 20.0% 55.0 15.0 9.3 0.5 コラゲナーゼ阻害剤 合計 00 %Placed directly gum base sugar glucose starch syrup fragrance According to the present invention Danshi (1!! Sumire) 20.0% 55.0 15.0 9.3 0.5 collagenase inhibitor total 00 %
Claims (4)
抽出物からなることを特徴とするコラゲナーゼ阻害剤。(1) A collagenase inhibitor comprising an extract extracted from cacao husk, which is the skin of cacao beans.
で抽出される疎水性物質を含有せず、水で抽出されない
抽出残渣を含有しない請求項1記載のコラゲナーゼ阻害
剤。(2) The collagenase inhibitor according to claim 1, which does not contain a hydrophobic substance extracted with an organic solvent from cacao husk, which is the hull of cacao beans, and does not contain an extraction residue that cannot be extracted with water.
ルよりなる群から選択される請求項2記載のコラゲナー
ゼ阻害剤。(3) The collagenase inhibitor according to claim 2, wherein the organic solvent is selected from the group consisting of hexane, acetone, and alcohol.
焙煎後に分離される豆皮である請求項1乃至3いずれか
に記載のコラゲナーゼ阻害剤。(4) The collagenase inhibitor according to any one of claims 1 to 3, wherein the cacao husk, which is the bean skin of cacao beans, is the bean skin separated after roasting the cacao beans.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1177186A JPH0344331A (en) | 1989-07-11 | 1989-07-11 | Collagenase inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1177186A JPH0344331A (en) | 1989-07-11 | 1989-07-11 | Collagenase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0344331A true JPH0344331A (en) | 1991-02-26 |
Family
ID=16026680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1177186A Pending JPH0344331A (en) | 1989-07-11 | 1989-07-11 | Collagenase inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0344331A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020541A1 (en) * | 1993-03-05 | 1994-09-15 | Groupe Celbert Sa | Collagenase activity inhibitor and cosmetic composition containing same |
JP2005350431A (en) * | 2004-06-14 | 2005-12-22 | Furabamin:Kk | Caffeine composition and its use |
-
1989
- 1989-07-11 JP JP1177186A patent/JPH0344331A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020541A1 (en) * | 1993-03-05 | 1994-09-15 | Groupe Celbert Sa | Collagenase activity inhibitor and cosmetic composition containing same |
JP2005350431A (en) * | 2004-06-14 | 2005-12-22 | Furabamin:Kk | Caffeine composition and its use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0477424A (en) | Preventive for periodontal disease | |
JP3635081B2 (en) | Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, external preparations for skin, cosmetics and foods | |
KR20070002409A (en) | Cosmetic composition containing as available ingredient the extracts of Equisetum arvense L. | |
JPH07252129A (en) | Agent for keeping corneal layer of epidermis healthy, prepared from rice | |
JPH0741426A (en) | Active oxygen scavenger from rice | |
KR101664025B1 (en) | Cosmetic composition containing natural herb extracts | |
KR20120140141A (en) | Cosmetic composition comprising the fermented extracts and the extracts of the rice | |
JPWO2004026273A1 (en) | Oral composition | |
JP2003201214A (en) | Matrix metalloprotease activity inhibitor | |
KR100431170B1 (en) | Compositions for Dental Clinic Comprising Extracts of Plant | |
JPH0344331A (en) | Collagenase inhibitor | |
WO2018190588A1 (en) | Aged rose extract and preparation method therefor | |
JP2005035907A (en) | Anti-periodontal disease medicine | |
JPH10287582A (en) | Suppressant for liberation of histamine comprising bark extract | |
JPH0645549B2 (en) | Anti periodontal drug | |
JP2999791B2 (en) | Method for enhancing glucosyltransferase inhibitory activity | |
JP3281716B2 (en) | Glucosyltransferase inhibitors, oral preparations and foods and drinks | |
KR20000038844A (en) | Whitening cosmetic base composition comprising mung bean extract | |
KR100314505B1 (en) | Composition of tooth paste and the process of preparation thereof | |
JP4198260B2 (en) | Cosmetics, quasi drugs, pharmaceuticals, food | |
KR102650192B1 (en) | Cosmetic composition comprising snowberry flesh and preparation method thereof | |
JP3795541B2 (en) | Lipid peroxide inhibitor from rice | |
JP3795543B2 (en) | 5α-reductase inhibitor | |
JP2000159679A (en) | Anticaries agent | |
JP2887696B2 (en) | Glucosyltransferase inhibitors and oral cleansing agents |